Ironwood Pharmaceuticals | IRWD - Koszty Sprzedaży I Administracji

Cena Akcji
3.11
Dzienna Zmiana
-0.18 -5.47%
Miesięcznie
-7.44%
Rocznie
107.33%
Q1 Prognozy TE
2.95




Koszty Sprzedaży I Administracji Zmiana Data
Acadia Pharmaceuticals USD 146.73M 21.82M 2025-12
Agios Pharmaceuticals USD 42.97M 1.7M 2025-12
Akebia Therapeutics USD 23.53M 3.19M 2025-12
Alnylam Pharmaceuticals USD 285.06M 22.47M 2025-12
Amarin USD 18.97M 1.03M 2025-12
Ardelyx USD 75.92M 7.69M 2025-12
Astellas Pharma JPY 221.78B 14.94B 2025-12
AstraZeneca USD 4.61B 4.46B 2025-12
Charles River Laboratories USD 196.14M 18.55M 2025-12
Coherus Biosciences USD 15M 6.26M 2025-12
Emergent BioSolutions USD 182.8M 82.3M 2023-06
Esperion Therapeutics USD 39.42M 456K 2025-12
Exact Sciences USD 491.64M 35.94M 2025-09
Halozyme Therapeutics USD 64.64M 27.11M 2025-12
Incyte USD 390.41M 61.33M 2025-12
Ironwood Pharmaceuticals USD 33.33M 2.78M 2024-12
Karyopharm Therapeutics USD 27.19M 442K 2024-12
Lexicon Pharmaceuticals USD 3.98M 195K 2025-12
MacroGenics USD 7.94M 1.96M 2025-12
Moderna USD 308M 40M 2025-12
Myriad Genetics USD 122.3M 6.7M 2025-12
Pacira USD 91.87M 70K 2025-12
PTC Therapeutics USD 87.2M 3.15M 2025-12
Puma Biotechnology USD 16.82M 8.15M 2024-09
Sarepta Therapeutics USD 105.38M 28.27M 2025-12
Takeda JPY 282.78B 29.23B 2025-12
Ultragenyx Pharmaceutical USD 89M 2.38M 2025-12
Vanda Pharmaceuticals USD 39.28M 1.71M 2024-12